AR098879A1 - Síntesis de ent-progesterona y sus productos intermedios - Google Patents
Síntesis de ent-progesterona y sus productos intermediosInfo
- Publication number
- AR098879A1 AR098879A1 ARP140104814A ARP140104814A AR098879A1 AR 098879 A1 AR098879 A1 AR 098879A1 AR P140104814 A ARP140104814 A AR P140104814A AR P140104814 A ARP140104814 A AR P140104814A AR 098879 A1 AR098879 A1 AR 098879A1
- Authority
- AR
- Argentina
- Prior art keywords
- ent
- compound
- formula
- synthesis
- progesterona
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
- C07J15/005—Retrosteroids (9 beta 10 alfa)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
- C07J75/005—Preparation of steroids by cyclization of non-steroid compounds
Abstract
Síntesis de ent-progesterona y sus compuestos intermedios. Reivindicación 1: Un método para la preparación de ent-progesterona que comprende el paso de la reacción de un compuesto de la fórmula (1) para producir un compuesto de la fórmula (2). Reivindicación 9: Un método para la preparación de ent-progesterona que comprende el paso de reacción de un compuesto de la fórmula (3) para producir un compuesto de la fórmula (4). Reivindicación 10: Un método para la preparación de ent-progesterona que comprende el paso de reacción de un compuesto de la fórmula (4) para producir un compuesto de la fórmula (5). Reivindicación 11: Un método para la preparación de ent-progesterona que comprende el paso de la reacción de un compuesto de la fórmula (5) para producir un compuesto de la fórmula (6).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361919420P | 2013-12-20 | 2013-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR098879A1 true AR098879A1 (es) | 2016-06-22 |
Family
ID=53399300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140104814A AR098879A1 (es) | 2013-12-20 | 2014-12-19 | Síntesis de ent-progesterona y sus productos intermedios |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20150175650A1 (es) |
| EP (1) | EP3083656A1 (es) |
| JP (1) | JP2017502031A (es) |
| CN (1) | CN105980396B (es) |
| AR (1) | AR098879A1 (es) |
| AU (1) | AU2014364850A1 (es) |
| BR (1) | BR112016014000A2 (es) |
| CA (1) | CA2934466A1 (es) |
| EA (1) | EA201691074A1 (es) |
| IL (1) | IL246258A0 (es) |
| MA (1) | MA39126B1 (es) |
| MX (1) | MX2016008167A (es) |
| PH (1) | PH12016501201A1 (es) |
| SG (1) | SG11201604982XA (es) |
| TN (1) | TN2016000252A1 (es) |
| TW (1) | TW201538519A (es) |
| UY (1) | UY35909A (es) |
| WO (1) | WO2015095339A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017100988A (ja) * | 2015-12-01 | 2017-06-08 | アサヒグループホールディングス株式会社 | 光学活性なヒドロキシ脂肪酸の製造方法 |
| IT201700004904A1 (it) * | 2017-01-18 | 2018-07-18 | Ind Chimica Srl | PROCESSO PER LA PREPARAZIONE DI 9β,10α-PROGESTERONE (RETROPROGESTERONE) |
| EP4007765A4 (en) * | 2019-08-02 | 2023-08-23 | Enterin, Inc. | HUMAN SQUALAMIN DERIVATIVES, COMPOSITIONS CONTAINING THEM, AND METHODS OF USE THEREOF |
| JP2022543242A (ja) * | 2019-08-02 | 2022-10-11 | エンターイン、 インコーポレイテッド | ヒトアミノステロールｅｎｔ－０３化合物、それを含む関連組成物、およびそれを使用する方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2955684A1 (en) * | 2008-02-26 | 2009-09-03 | Emory University | Steroid analogues for neuroprotection |
| WO2010088409A2 (en) * | 2009-01-30 | 2010-08-05 | Emory University | Methods of neuroprotection using neuroprotective steroids and a vitamin d |
| EP2763679A4 (en) * | 2011-10-07 | 2016-06-01 | Univ Florida State Res Found | PROPHYLACTIC AND POSTACLE USE OF PROGESTERONE FOR BETTER TREATMENT RESULTS IN BRAIN DISORDER |
-
2014
- 2014-12-17 CA CA2934466A patent/CA2934466A1/en not_active Abandoned
- 2014-12-17 MX MX2016008167A patent/MX2016008167A/es unknown
- 2014-12-17 BR BR112016014000A patent/BR112016014000A2/pt not_active IP Right Cessation
- 2014-12-17 WO PCT/US2014/070879 patent/WO2015095339A1/en active Application Filing
- 2014-12-17 MA MA39126A patent/MA39126B1/fr unknown
- 2014-12-17 AU AU2014364850A patent/AU2014364850A1/en not_active Abandoned
- 2014-12-17 EA EA201691074A patent/EA201691074A1/ru unknown
- 2014-12-17 SG SG11201604982XA patent/SG11201604982XA/en unknown
- 2014-12-17 TN TN2016000252A patent/TN2016000252A1/en unknown
- 2014-12-17 JP JP2016541444A patent/JP2017502031A/ja active Pending
- 2014-12-17 CN CN201480072282.4A patent/CN105980396B/zh not_active Expired - Fee Related
- 2014-12-17 US US14/573,656 patent/US20150175650A1/en not_active Abandoned
- 2014-12-17 EP EP14871117.9A patent/EP3083656A1/en not_active Withdrawn
- 2014-12-19 UY UY0001035909A patent/UY35909A/es not_active Application Discontinuation
- 2014-12-19 TW TW103144457A patent/TW201538519A/zh unknown
- 2014-12-19 AR ARP140104814A patent/AR098879A1/es unknown
-
2016
- 2016-06-16 IL IL246258A patent/IL246258A0/en unknown
- 2016-06-20 PH PH12016501201A patent/PH12016501201A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY35909A (es) | 2015-07-31 |
| JP2017502031A (ja) | 2017-01-19 |
| AU2014364850A1 (en) | 2016-07-07 |
| SG11201604982XA (en) | 2016-07-28 |
| MA39126A3 (fr) | 2019-04-30 |
| MA39126A2 (fr) | 2018-08-31 |
| CN105980396B (zh) | 2019-03-22 |
| CN105980396A (zh) | 2016-09-28 |
| EP3083656A1 (en) | 2016-10-26 |
| WO2015095339A1 (en) | 2015-06-25 |
| BR112016014000A2 (pt) | 2017-08-08 |
| PH12016501201A1 (en) | 2016-08-15 |
| CA2934466A1 (en) | 2015-06-25 |
| EA201691074A1 (ru) | 2017-02-28 |
| MA39126B1 (fr) | 2020-03-31 |
| MX2016008167A (es) | 2017-04-27 |
| IL246258A0 (en) | 2016-08-02 |
| US20150175650A1 (en) | 2015-06-25 |
| TW201538519A (zh) | 2015-10-16 |
| TN2016000252A1 (en) | 2017-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112016028773A2 (pt) | processos para preparação de compostos antivirais | |
| ECSP15043280A (es) | Nuevos compuestos y composiciones para la inhibición de fasn | |
| BR112016029333A2 (pt) | síntese de compostos de carbamoilpiridona policíclico | |
| BR112014030365A2 (pt) | síntese de composto antiviral | |
| UY35700A (es) | Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de la fibrosis quística | |
| CR20140534A (es) | Proceso para la preparación de treprostinil y derivado de los mismos | |
| CU24354B1 (es) | Procedimiento de obtención de derivados de tetrafluoropropilmorfolina | |
| CR20140435A (es) | Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos | |
| BR112015008117A2 (pt) | benzamidas | |
| CO7200265A2 (es) | Proceso para la preparación de 4-amino-5-flúor-3-halo-6-picolinatos(substituidos) | |
| CO2018004581A2 (es) | Compuestos de criptoficina y productos conjugados, y sus métodos de preparación | |
| UA111333C2 (uk) | Спосіб одержання l-аргінінової солі периндроприлу | |
| AR098879A1 (es) | Síntesis de ent-progesterona y sus productos intermedios | |
| CO6751286A2 (es) | Síntesis de derivados de 2-carboxamida-cicloamino-urea | |
| CY1121116T1 (el) | Νεα μεθοδος για την συνθεση αγομελατινης | |
| BR112015024859A2 (pt) | processo e intermediários para a preparação de pregabalina | |
| AR101951A1 (es) | Síntesis de ent-progesterona e intermediarios de la misma | |
| CR20150387A (es) | Proceso para producir compuesto de piridazinona y producción de sus intermediarios | |
| BR112015026759A2 (pt) | síntese de inibidores bace | |
| BR112015009720A2 (pt) | método para a preparação de um composto de fórmula (i) e intermediários de síntese. | |
| ES2670477R1 (es) | Procedimiento para la preparacion de la 17beta-hidroxi-des-a-androst-9,10-en-5-ona | |
| UY35561A (es) | Procedimiento de síntesis del 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7- carbonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable | |
| MX2016005511A (es) | Intermediarios y metodos para sintetizar derivados de calicheamicina. | |
| EA201400188A1 (ru) | Способ получения кристаллической формы i агомелатина | |
| UY35503A (es) | Titulo: procedimiento de síntesis de derivados de la 7,8-dimetoxi-1,3 -dihidro-2h-3- benzazepin -2- ona y aplicación a la síntesis de la ivabradina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |